Several studies have shown that a number of candidate genes cause seizures in glioma patients, such as interleukin-1β (IL-1β) [50], CD34 [51], and tuberous sclerosis complex (TSC) [52]. The gene discussed is CD34; the disease is central nervous system cancer.